VICP & CICP injury tables — what’s compensable, what’s being evaluated

CICP rulemaking announced — COVID-19 injury table. HHS/HRSA has announced plans to establish a CICP COVID-19 vaccine injury table (NPRM expected November 2026). The public comment period is not yet open. Lawsuit (Flores v. HHS, filed May 2026) to compel a table required under the PREP Act. This reports the procedural status of a rulemaking, not a finding that any vaccine caused any injury. source.

A Table listing is a legal presumption for a compensation program, not a scientific finding that the vaccine caused the injury in a given person, and not incidence. Off-Table claims can still be filed; they require proof of causation under that program’s statute. This page quotes public-domain CFR text and does not give legal advice.

How to read this. Left/official: injuries currently listed in 42 C.F.R. § 100.3 (VICP) and § 110.100 (CICP). Right/candidates: injuries this project is tracking for a possible Table petition. A candidate is not a finding that the injury belongs on a Table. Each candidate shows what’s blocking this from computed Evidence Matrix claim statuses (C1–C6). Stages past evidence-gathering cannot be set without those gates, or a recorded override.

Official Table browser

Filter by program. QAI (Qualifications and Aids to Interpretation) is quoted from eCFR with retrieval date. Table versions are append-only.

National Vaccine Injury Compensation Program 42 C.F.R. § 100.3

Effective 2017-02-21 · version vicp-2017-02-21 · eCFR source

Current Vaccine Injury Table as amended (82 FR 6299, Jan. 19, 2017; 86 FR 68427, Dec. 2, 2021). Seeded from eCFR retrieval 2026-09-05. Append-only: a later rulemaking becomes a new version, not an edit.

Generally 3 years from first symptom of the injury (death claims have a separate 2-year rule). · Appeal: U.S. Court of Federal Claims (Vaccine Court), with further appellate review.

Countermeasure / vaccine	Injury	Onset window	QAI (quoted)
Vaccines containing tetanus toxoid (e.g., DTaP, DTP, DT, Td, or TT)	Anaphylaxis	≤4 hours	QAI excerpt Anaphylaxis is an acute, severe, and potentially lethal systemic reaction that occurs as a single discrete event with simultaneous involvement of two or more organ systems. Signs and symptoms begin minutes to a few hours after exposure. Source: https://www.ecfr.gov/current/title-42/section-100.3 · retrieved 2026-09-05
Vaccines containing tetanus toxoid (e.g., DTaP, DTP, DT, Td, or TT)	Brachial neuritis	2–28 days (not less than 2 days and not more than 28 days)	QAI excerpt Brachial neuritis is dysfunction limited to the upper extremity nerve plexus. A deep, steady, often severe aching pain in the shoulder and upper arm usually heralds onset, typically followed in days or weeks by weakness in the affected upper extremity muscle groups. Source: https://www.ecfr.gov/current/title-42/section-100.3 · retrieved 2026-09-05
Vaccines containing tetanus toxoid (e.g., DTaP, DTP, DT, Td, or TT)	Shoulder Injury Related to Vaccine Administration	≤48 hours	QAI excerpt SIRVA manifests as shoulder pain and limited range of motion occurring after the administration of a vaccine intended for intramuscular administration in the upper arm. SIRVA is caused by an injury to the musculoskeletal structures of the shoulder. SIRVA is not a neurological injury. Source: https://www.ecfr.gov/current/title-42/section-100.3 · retrieved 2026-09-05
Vaccines containing tetanus toxoid (e.g., DTaP, DTP, DT, Td, or TT)	Vasovagal syncope	≤1 hour	QAI excerpt Vasovagal syncope means loss of consciousness (fainting) and postural tone caused by a transient decrease in blood flow to the brain occurring after the administration of an injected vaccine. Source: https://www.ecfr.gov/current/title-42/section-100.3 · retrieved 2026-09-05
Vaccines containing pertussis antigen(s) (e.g., DTP, DTaP, P, DTP-Hib)	Anaphylaxis	≤4 hours	QAI excerpt Anaphylaxis is an acute, severe, and potentially lethal systemic reaction that occurs as a single discrete event with simultaneous involvement of two or more organ systems. Signs and symptoms begin minutes to a few hours after exposure. Source: https://www.ecfr.gov/current/title-42/section-100.3 · retrieved 2026-09-05
Vaccines containing pertussis antigen(s) (e.g., DTP, DTaP, P, DTP-Hib)	Encephalopathy or encephalitis	≤72 hours	QAI excerpt A vaccine recipient shall be considered to have suffered an encephalopathy if an injury meeting the description of an acute encephalopathy occurs within the applicable time period and results in a chronic encephalopathy. Source: https://www.ecfr.gov/current/title-42/section-100.3 · retrieved 2026-09-05
Vaccines containing pertussis antigen(s) (e.g., DTP, DTaP, P, DTP-Hib)	Shoulder Injury Related to Vaccine Administration	≤48 hours	QAI excerpt SIRVA manifests as shoulder pain and limited range of motion occurring after the administration of a vaccine intended for intramuscular administration in the upper arm. SIRVA is caused by an injury to the musculoskeletal structures of the shoulder. SIRVA is not a neurological injury. Source: https://www.ecfr.gov/current/title-42/section-100.3 · retrieved 2026-09-05
Vaccines containing pertussis antigen(s) (e.g., DTP, DTaP, P, DTP-Hib)	Vasovagal syncope	≤1 hour	QAI excerpt Vasovagal syncope means loss of consciousness (fainting) and postural tone caused by a transient decrease in blood flow to the brain occurring after the administration of an injected vaccine. Source: https://www.ecfr.gov/current/title-42/section-100.3 · retrieved 2026-09-05
Vaccines containing measles, mumps, and rubella virus or any of its components (e.g., MMR, MM, MMRV)	Anaphylaxis	≤4 hours	QAI excerpt Anaphylaxis is an acute, severe, and potentially lethal systemic reaction that occurs as a single discrete event with simultaneous involvement of two or more organ systems. Signs and symptoms begin minutes to a few hours after exposure. Source: https://www.ecfr.gov/current/title-42/section-100.3 · retrieved 2026-09-05
Vaccines containing measles, mumps, and rubella virus or any of its components (e.g., MMR, MM, MMRV)	Encephalopathy or encephalitis	5–15 days (not less than 5 days and not more than 15 days)	QAI excerpt A vaccine recipient shall be considered to have suffered an encephalopathy if an injury meeting the description of an acute encephalopathy occurs within the applicable time period and results in a chronic encephalopathy. Source: https://www.ecfr.gov/current/title-42/section-100.3 · retrieved 2026-09-05
Vaccines containing measles, mumps, and rubella virus or any of its components (e.g., MMR, MM, MMRV)	Shoulder Injury Related to Vaccine Administration	≤48 hours	QAI excerpt SIRVA manifests as shoulder pain and limited range of motion occurring after the administration of a vaccine intended for intramuscular administration in the upper arm. SIRVA is caused by an injury to the musculoskeletal structures of the shoulder. SIRVA is not a neurological injury. Source: https://www.ecfr.gov/current/title-42/section-100.3 · retrieved 2026-09-05
Vaccines containing measles, mumps, and rubella virus or any of its components (e.g., MMR, MM, MMRV)	Vasovagal syncope	≤1 hour	QAI excerpt Vasovagal syncope means loss of consciousness (fainting) and postural tone caused by a transient decrease in blood flow to the brain occurring after the administration of an injected vaccine. Source: https://www.ecfr.gov/current/title-42/section-100.3 · retrieved 2026-09-05
Vaccines containing rubella virus (e.g., MMR, MMRV)	Chronic arthritis	7–42 days (not less than 7 days and not more than 42 days)	QAI excerpt No condition covered. Source: https://www.ecfr.gov/current/title-42/section-100.3 · retrieved 2026-09-05
Vaccines containing measles virus (e.g., MMR, MM, MMRV)	Thrombocytopenic purpura	7–30 days (not less than 7 days and not more than 30 days)	QAI excerpt Thrombocytopenic purpura is defined by clinical manifestations such as petechiae, significant bruising, or spontaneous bleeding, and by a serum platelet count less than 50,000/mm3 with normal red and white blood cell indices. Source: https://www.ecfr.gov/current/title-42/section-100.3 · retrieved 2026-09-05
Vaccines containing polio inactivated virus (e.g., IPV)	Anaphylaxis	≤4 hours	QAI excerpt Anaphylaxis is an acute, severe, and potentially lethal systemic reaction that occurs as a single discrete event with simultaneous involvement of two or more organ systems. Signs and symptoms begin minutes to a few hours after exposure. Source: https://www.ecfr.gov/current/title-42/section-100.3 · retrieved 2026-09-05
Vaccines containing polio inactivated virus (e.g., IPV)	Shoulder Injury Related to Vaccine Administration	≤48 hours	QAI excerpt SIRVA manifests as shoulder pain and limited range of motion occurring after the administration of a vaccine intended for intramuscular administration in the upper arm. SIRVA is caused by an injury to the musculoskeletal structures of the shoulder. SIRVA is not a neurological injury. Source: https://www.ecfr.gov/current/title-42/section-100.3 · retrieved 2026-09-05
Vaccines containing polio inactivated virus (e.g., IPV)	Vasovagal syncope	≤1 hour	QAI excerpt Vasovagal syncope means loss of consciousness (fainting) and postural tone caused by a transient decrease in blood flow to the brain occurring after the administration of an injected vaccine. Source: https://www.ecfr.gov/current/title-42/section-100.3 · retrieved 2026-09-05
Hepatitis B vaccines	Anaphylaxis	≤4 hours	QAI excerpt Anaphylaxis is an acute, severe, and potentially lethal systemic reaction that occurs as a single discrete event with simultaneous involvement of two or more organ systems. Signs and symptoms begin minutes to a few hours after exposure. Source: https://www.ecfr.gov/current/title-42/section-100.3 · retrieved 2026-09-05
Hepatitis B vaccines	Shoulder Injury Related to Vaccine Administration	≤48 hours	QAI excerpt SIRVA manifests as shoulder pain and limited range of motion occurring after the administration of a vaccine intended for intramuscular administration in the upper arm. SIRVA is caused by an injury to the musculoskeletal structures of the shoulder. SIRVA is not a neurological injury. Source: https://www.ecfr.gov/current/title-42/section-100.3 · retrieved 2026-09-05
Haemophilus influenzae type b (Hib) vaccines	Shoulder Injury Related to Vaccine Administration	≤48 hours	QAI excerpt SIRVA manifests as shoulder pain and limited range of motion occurring after the administration of a vaccine intended for intramuscular administration in the upper arm. SIRVA is caused by an injury to the musculoskeletal structures of the shoulder. SIRVA is not a neurological injury. Source: https://www.ecfr.gov/current/title-42/section-100.3 · retrieved 2026-09-05
Varicella vaccines	Anaphylaxis	≤4 hours	QAI excerpt Anaphylaxis is an acute, severe, and potentially lethal systemic reaction that occurs as a single discrete event with simultaneous involvement of two or more organ systems. Signs and symptoms begin minutes to a few hours after exposure. Source: https://www.ecfr.gov/current/title-42/section-100.3 · retrieved 2026-09-05
Varicella vaccines	Shoulder Injury Related to Vaccine Administration	≤48 hours	QAI excerpt SIRVA manifests as shoulder pain and limited range of motion occurring after the administration of a vaccine intended for intramuscular administration in the upper arm. SIRVA is caused by an injury to the musculoskeletal structures of the shoulder. SIRVA is not a neurological injury. Source: https://www.ecfr.gov/current/title-42/section-100.3 · retrieved 2026-09-05
Rotavirus vaccines	Intussusception	1–21 days (not less than 1 day and not more than 21 days)	QAI excerpt Intussusception means the invagination of a segment of intestine into the next segment of intestine, resulting in bowel obstruction. Onset that occurs with or after the third dose of a rotavirus vaccine is not a Table intussusception. Source: https://www.ecfr.gov/current/title-42/section-100.3 · retrieved 2026-09-05
Pneumococcal conjugate vaccines	Shoulder Injury Related to Vaccine Administration	≤48 hours	QAI excerpt SIRVA manifests as shoulder pain and limited range of motion occurring after the administration of a vaccine intended for intramuscular administration in the upper arm. SIRVA is caused by an injury to the musculoskeletal structures of the shoulder. SIRVA is not a neurological injury. Source: https://www.ecfr.gov/current/title-42/section-100.3 · retrieved 2026-09-05
Hepatitis A vaccines	Shoulder Injury Related to Vaccine Administration	≤48 hours	QAI excerpt SIRVA manifests as shoulder pain and limited range of motion occurring after the administration of a vaccine intended for intramuscular administration in the upper arm. SIRVA is caused by an injury to the musculoskeletal structures of the shoulder. SIRVA is not a neurological injury. Source: https://www.ecfr.gov/current/title-42/section-100.3 · retrieved 2026-09-05
Seasonal influenza vaccines	Anaphylaxis	≤4 hours	QAI excerpt Anaphylaxis is an acute, severe, and potentially lethal systemic reaction that occurs as a single discrete event with simultaneous involvement of two or more organ systems. Signs and symptoms begin minutes to a few hours after exposure. Source: https://www.ecfr.gov/current/title-42/section-100.3 · retrieved 2026-09-05
Seasonal influenza vaccines	Shoulder Injury Related to Vaccine Administration	≤48 hours	QAI excerpt SIRVA manifests as shoulder pain and limited range of motion occurring after the administration of a vaccine intended for intramuscular administration in the upper arm. SIRVA is caused by an injury to the musculoskeletal structures of the shoulder. SIRVA is not a neurological injury. Source: https://www.ecfr.gov/current/title-42/section-100.3 · retrieved 2026-09-05
Seasonal influenza vaccines	Vasovagal syncope	≤1 hour	QAI excerpt Vasovagal syncope means loss of consciousness (fainting) and postural tone caused by a transient decrease in blood flow to the brain occurring after the administration of an injected vaccine. Source: https://www.ecfr.gov/current/title-42/section-100.3 · retrieved 2026-09-05
Seasonal influenza vaccines	Guillain-Barré Syndrome	3–42 days (not less than 3 days and not more than 42 days)	QAI excerpt GBS is an acute monophasic peripheral neuropathy. The interval between the first appearance of symptoms and the nadir of weakness is between 12 hours and 28 days. Exclusionary criteria include CIDP and a list of more-likely alternative diagnoses. Source: https://www.ecfr.gov/current/title-42/section-100.3 · retrieved 2026-09-05
Meningococcal vaccines	Anaphylaxis	≤4 hours	QAI excerpt Anaphylaxis is an acute, severe, and potentially lethal systemic reaction that occurs as a single discrete event with simultaneous involvement of two or more organ systems. Signs and symptoms begin minutes to a few hours after exposure. Source: https://www.ecfr.gov/current/title-42/section-100.3 · retrieved 2026-09-05
Human papillomavirus (HPV) vaccines	Anaphylaxis	≤4 hours	QAI excerpt Anaphylaxis is an acute, severe, and potentially lethal systemic reaction that occurs as a single discrete event with simultaneous involvement of two or more organ systems. Signs and symptoms begin minutes to a few hours after exposure. Source: https://www.ecfr.gov/current/title-42/section-100.3 · retrieved 2026-09-05
Human papillomavirus (HPV) vaccines	Shoulder Injury Related to Vaccine Administration	≤48 hours	QAI excerpt SIRVA manifests as shoulder pain and limited range of motion occurring after the administration of a vaccine intended for intramuscular administration in the upper arm. SIRVA is caused by an injury to the musculoskeletal structures of the shoulder. SIRVA is not a neurological injury. Source: https://www.ecfr.gov/current/title-42/section-100.3 · retrieved 2026-09-05

Countermeasures Injury Compensation Program 42 C.F.R. § 110.100

Effective 2011-10-01 · version cicp-110.100-current · eCFR source

Covered Countermeasures Injury Table as displayed on eCFR (pandemic influenza rows). COVID-19 vaccines have no Table condition in this version. Retrieval 2026-09-05.

1 year from the date the covered countermeasure was administered or used. · Appeal: Request for reconsideration to the Secretary of HHS only — no Vaccine Court.

Countermeasure / vaccine	Injury	Onset window	QAI (quoted)
Pandemic influenza vaccines administered by needle into or through the skin	Anaphylaxis	0–4 hours	QAI excerpt Anaphylaxis is an acute, severe, and potentially lethal systemic reaction that occurs as a single discrete event with simultaneous involvement of two or more organ systems. Signs and symptoms begin minutes to a few hours after exposure. Source: https://www.ecfr.gov/current/title-42/section-110.100 · retrieved 2026-09-05
Pandemic influenza vaccines administered by needle into or through the skin	Deltoid bursitis	0–48 hours	QAI excerpt SIRVA manifests as shoulder pain and limited range of motion occurring after the administration of a vaccine intended for intramuscular administration in the upper arm. SIRVA is caused by an injury to the musculoskeletal structures of the shoulder. SIRVA is not a neurological injury. Source: https://www.ecfr.gov/current/title-42/section-110.100 · retrieved 2026-09-05 CICP uses deltoid bursitis; related to but not identical to VICP SIRVA.
Pandemic influenza vaccines administered by needle into or through the skin	Vasovagal syncope	0–1 hour	QAI excerpt Vasovagal syncope means loss of consciousness (fainting) and postural tone caused by a transient decrease in blood flow to the brain occurring after the administration of an injected vaccine. Source: https://www.ecfr.gov/current/title-42/section-110.100 · retrieved 2026-09-05
Pandemic influenza intranasal vaccines	Anaphylaxis	0–4 hours	QAI excerpt Anaphylaxis is an acute, severe, and potentially lethal systemic reaction that occurs as a single discrete event with simultaneous involvement of two or more organ systems. Signs and symptoms begin minutes to a few hours after exposure. Source: https://www.ecfr.gov/current/title-42/section-110.100 · retrieved 2026-09-05
Pandemic influenza 2009 H1N1 vaccine	Guillain-Barré Syndrome	3–42 days (not less than 72 hours and not more than 42 days)	QAI excerpt GBS is an acute monophasic peripheral neuropathy. The interval between the first appearance of symptoms and the nadir of weakness is between 12 hours and 28 days. Exclusionary criteria include CIDP and a list of more-likely alternative diagnoses. Source: https://www.ecfr.gov/current/title-42/section-110.100 · retrieved 2026-09-05
COVID-19 vaccines (covered PREP Act countermeasures)	No condition covered	Not applicable	QAI excerpt No condition covered. Source: https://www.ecfr.gov/current/title-42/section-110.100 · retrieved 2026-09-05 COVID-19 vaccines are covered countermeasures under CICP, but as of this TableVersion they have no Table injury. Claims may still be compensated off-Table if causation is shown by compelling, reliable, valid medical and scientific evidence. That is a higher bar than a Table presumption.

Currently compensable vs being evaluated

COVID-19 vaccines are covered by CICP, not VICP. The CICP Table currently lists no COVID-19-specific injury. Seasonal influenza GBS is on the VICP Table. That difference is statutory coverage, not a statement about relative harm.

Myocarditis / pericarditis after COVID-19 mRNA vaccine

petition drafted

Target: CICP · COVID-19 mRNA vaccines · proposed window: 0–7 days (dose 2, especially males 12–29)

Claims (computed): C1=supported · C2=supported · C3=contested · C4=contested · C5=supported · C6=supported · 5 of 9 Hill criteria addressed

What’s blocking this.

No regulations.gov docket_number on the Docket record (petition_filed is a manual acknowledgement gate).

Free-text blocker (legacy): No regulations.gov docket_number on the Docket record (petition_filed is a manual acknowledgement gate).

Pipeline board / docket → Stage history is append-only. 2026-09-05 · actor phase2-fill-gaps.

Small-fiber neuropathy / POTS after COVID-19 vaccine (PACVS-related hypothesis)

evidence gathering

Target: CICP · COVID-19 vaccines · proposed window: 0–42 days (not locked — case-series range; Kwan used 90-day sequence-symmetry)

Claims (computed): C1=supported · C2=supported · C3=insufficient_data · C4=insufficient_data · C5=insufficient_data · C6=supported · 4 of 9 Hill criteria addressed

What’s blocking this.

C3 (Epidemiologic excess risk) is insufficient_data — populate/search nodes B1, B3.
C4 (Consistency / replication) is insufficient_data — populate/search nodes B5, B6.
C5 (Specificity (product / dose)) is insufficient_data — populate/search nodes C1n, C2n.

Free-text blocker (legacy): C3 (Epidemiologic excess risk) is insufficient_data — populate/search nodes B1, B3. C4 (Consistency / replication) is insufficient_data — populate/search nodes B5, B6. C5 (Specificity (product / dose)) is insufficient_data — populate/search nodes C1n, C2n.

Pipeline board / docket → Stage history is append-only. 2026-09-05 · actor phase2-fill-gaps.

Denied candidates stay visible permanently. Pipeline board (kanban, dockets, eCFR watch): compensation-pipeline.html. Reproduce: python -m tables_workflow build. Data: data/tables_workflow/tables_workflow.json.

What’s on the compensation Tables